Bevin Gangadharan
Overview
Explore the profile of Bevin Gangadharan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arman B, Clarke R, Bharucha T, Fernandez L, Walsby-Tickle J, Deats M, et al.
NPJ Vaccines
. 2025 Jan;
10(1):19.
PMID: 39885196
The rapid development and worldwide distribution of COVID-19 vaccines is a remarkable achievement of biomedical research and logistical implementation. However, these developments are associated with the risk of a surge...
2.
Clarke R, Bharucha T, Arman B, Gangadharan B, Fernandez L, Mosca S, et al.
NPJ Vaccines
. 2024 Aug;
9(1):155.
PMID: 39198486
The global population is increasingly reliant on vaccines to maintain population health with billions of doses used annually in immunisation programmes. Substandard and falsified vaccines are becoming more prevalent, caused...
3.
Bharucha T, Gangadharan B, Clarke R, Fernandez L, Arman B, Walsby-Tickle J, et al.
Vaccine
. 2024 Feb;
42(7):1506-1511.
PMID: 38355318
Substandard (including degraded) and falsified (SF) vaccines are a relatively neglected issue with serious global implications for public health. This has been highlighted during the rapid and widespread rollout of...
4.
Mosca S, Lin Q, Stokes R, Bharucha T, Gangadharan B, Clarke R, et al.
Vaccine
. 2023 Oct;
41(47):6960-6968.
PMID: 37865599
Preventing, detecting, and responding to substandard and falsified vaccines is of critical importance for ensuring the safety, efficacy, and public trust in vaccines. This is of heightened importance in context...
5.
Bharucha T, Gangadharan B, Kumar A, Myall A, Ayhan N, Pastorino B, et al.
J Proteome Res
. 2023 May;
22(6):1614-1629.
PMID: 37219084
Japanese encephalitis virus is a leading cause of neurological infection in the Asia-Pacific region with no means of detection in more remote areas. We aimed to test the hypothesis of...
6.
Tyrrell B, Kumar A, Gangadharan B, Alonzi D, Brun J, Hill M, et al.
Pathogens
. 2023 Mar;
12(3).
PMID: 36986321
Crimean-Congo haemorrhagic fever virus (CCHFV) is a pathogen of increasing public health concern, being a widely distributed arbovirus and the causative agent of the potentially fatal Crimean-Congo haemorrhagic fever. Hazara...
7.
Brun J, Vasiljevic S, Gangadharan B, Hensen M, Chandran A, Hill M, et al.
ACS Cent Sci
. 2021 May;
7(4):586-593.
PMID: 34056088
Severe acute respiratory syndrome coronavirus 2 is the causative pathogen of the COVID-19 pandemic which as of March 29, 2021, has claimed 2 776 175 lives worldwide. Vaccine development efforts...
8.
Bharucha T, Gangadharan B, Kumar A, de Lamballerie X, Newton P, Winterberg M, et al.
J Infect
. 2019 Aug;
79(5):407-418.
PMID: 31404562
Objectives: Central nervous system (CNS) infections account for considerable death and disability every year. An urgent research priority is scaling up diagnostic capacity, and introduction of point-of-care tests. We set...
9.
Kumar A, Gangadharan B, Cobbold J, Thursz M, Zitzmann N
Sci Rep
. 2017 Sep;
7(1):12072.
PMID: 28935895
LC-MS and immunoassay can detect protein biomarkers. Immunoassays are more commonly used but can potentially be outperformed by LC-MS. These techniques have limitations including the necessity to generate separate calibration...
10.
Kumar A, Gangadharan B, Zitzmann N
J Chromatogr B Analyt Technol Biomed Life Sci
. 2016 Sep;
1033-1034:278-286.
PMID: 27592286
Apolipoprotein F (APO-F) is a novel low abundance liver fibrosis biomarker and its concentration decreases in human serum and plasma across liver fibrosis stages. Current antibody based assays for APO-F...